Wednesday, 15 August 2018 - 9:56
  • it
  • de
  • en
  • fr


Aimmune’s peanut allergy drug successful

US-based biotech Aimmune Therapeutics yesterday announced positive clinical results from its Phase-III Parisade clinical trial enrolling 554 patients with peanut allergy, treated with the AR101 investigational therapy. The results have demonstrated that 2/3 of the patients better tolerate at least…

Google now offering tests to assess clinical depression

By Googling the word “depression”, users now have the opportunity to undergo a clinical test assessing their levels of depressive symptoms. The test was co-developed by the same Google and the National Alliance on Mental Illness (NAMI). There is widespread…